BMY | tickerfilter.com

Fundamental analysis

40%

Profitability 23%

Dept financing 48%

Liquidity 71%

Performance 49%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

3.82%

1 Month

1.83%

3 Months

25.99%

6 Months

0.75%

1 Year

-15.96%

2 Year

-19.41%

Key data

Stock price

$49.95

P/E Ratio

-15.48

DAY RANGE

$49.68 - $50.24

EPS

-$3.21

52 WEEK RANGE

$39.04 - $59.08

52 WEEK CHANGE

-$0.15

MARKET CAP

101.268 B

YIELD

4.65%

SHARES OUTSTANDING

2.027 B

DIVIDEND

$0.60

EX-DIVIDEND DATE

07/05/2024

NEXT EARNINGS DATE

10/31/2024

BETA

0.38

PUBLIC FLOAT

AVERAGE 10 VOLUME

$7,953,408

AVERAGE 30 VOLUME

$11,734,460

Company detail

CEO: Giovanni Caforio
Region: US
Website: https://www.bms.com/
Employees: 34,300
IPO year: -

Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.

BMY - Bristol-Myers Squibb Co.